Nido Biosciences Funding: $109M Raised, Series B (2023)
Nido Biosciences is based in Boston. It has raised $109M in total funding. Latest round: Series B.
Nido Biosciences funding overview
Nido Biosciences is based in Boston. Nido Biosciences has raised $109M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series B announced in May 2023. The round record for Nido Biosciences runs through 2023; nothing later has been disclosed. Investors on record include Bioluminescence Ventures, Eli Lilly, Bessemer Venture Partners, 5AM Ventures, Abingworth, Osage University Partners. 6 distinct backers are named across the disclosed rounds.
Nido Biosciences at a glance
Total raised
$109M
Latest round
Series B
Latest round date
May 2023
Headquarters
Boston
Notable investors
Bioluminescence Ventures, Eli Lilly, Bessemer Venture Partners, 5AM Ventures, Abingworth, Osage University Partners
Frequently asked about Nido Biosciences funding
How much has Nido Biosciences raised?
Nido Biosciences has raised $109M in total disclosed funding across the rounds on record.
Who has invested in Nido Biosciences?
Bioluminescence Ventures, Eli Lilly, Bessemer Venture Partners, 5AM Ventures, Abingworth, Osage University Partners are named among the investors backing Nido Biosciences.
What was the latest Nido Biosciences funding round?
The most recent disclosed round is a Series B, announced in May 2023.
Where is Nido Biosciences based?
Nido Biosciences is based in Boston.
When did Nido Biosciences last raise?
The last disclosed Nido Biosciences round closed in May 2023 at Series B.
Nido Biosciences totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Boston below to benchmark round size and investor mix.
